期刊文献+

系统性红斑狼疮患者外周血单个核细胞干扰素诱导的蛋白10mRNA表达的临床价值

Study on the expression of PBMCs IP-10 mRNA and systemic lupus erythematosus
原文传递
导出
摘要 目的探讨外周血单个核细胞(PBMCs)干扰素诱导的蛋白10(IP-10)mRNA 表达与系统性红斑狼疮(SLE)活动的关系。方法用逆转录-聚合酶链反应(RT-PCR)检测46例 SLE 患者、20例类风湿关节炎(RA)患者、11例非 SLE 肾损伤患者及20名正常健康人 PBMCs IP-10 mRNA 表达。结果 SLE 活动组 PBMCs IP-10 mRNA 表达水平与非活动组间的差异有统计学意义(P<0.01),活动性狼疮肾炎(LN)组与无肾损伤组之间 PBMCs IP-10 mRNA 表达水平的差异亦有统计学意义(P<0.05),而 RA 组和非 SLE 肾病组患者与正常对照组水平相近似(P>0.05)。血清 IP-10水平与PBMCs IP-10 mRNA 表达高度正相关(r=0.8971,P<0.01)。PBMCs IP-10 mRNA 表达水平与狼疮病活动指数(SLEDAI)评分呈正相关(r=0.683 7,P<0.01),与肾 SLEDAI 评分亦高度正相关(r=0.726 0,P<0.01)。结论 SLE 活动时期 PBMCs IP-10 mRNA 表达增加,与 SLE 疾病活动状况相关,尤其与 LN 的活动状况密切相关。 Objective To explore the relation between the expression of PBMCs IP-10 mRNA and systemic lupus erythematosus. Methods The expression of PBMCs IP-10 mRNA was investigated by RT-PCR semi quantitative method and samples from 46 patients with SLE, 20 patients with RA, 11 non-SLE patients with renal impairment and 20 healthy volunteers. Results The expression of PBMCs IP-10 mRNA in active SLE group was significantly higher than that in inactive group( P 〈 0.01 ), and there was significant difference between the active LN group and the no-renal involvement group ( P 〈 0. 05 ). Low expression levels of PBMCs IP-10mRNA were showed in diseased controls and the healthy control ( P 〉 0. 05 ). Serum levels of IP-10 were highly correlated with the expression levels of PBMCs IP-10 mRNA(r =0. 897 1, P 〈 0. 01 ). Furthermore, there was a close correlation between the expression of PBMCs IP-10mRNA and the overall SLEDAI score ( r =0.683 7, P 〈 0.0 1 ) and the SLEDAI renal score ( r =0. 726 0, P 〈0. 01 ). Condusion The expression of PBMCs IP-10 mRNA is significantly correlated with the activity of SLE, and closely correlated with the activity of LN, especially.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第9期784-786,共3页 Chinese Journal of Laboratory Medicine
关键词 系统性 红斑狼疮 逆转录聚合酶链反应 Lupus erythematosus,systemic Reverse transcriptase polymerase-chain reaction
  • 相关文献

参考文献13

  • 1Eriksson C, Eneslatt K, Ivanaff J, et al. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus. Lupus, 2003, 12: 766-774.
  • 2Yamada M, Yagita H, Inoue H, et al. Selective accumulation of CCR4 + T lymphocytes into renal tissue of patients with lupus nephritis. Arthritis Rheum,2002, 46: 735-740.
  • 3Narumi S, Takeuchi T, Kobayashi Y, et al. Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus. Cytokine, 2000,12 : 1561-1565.
  • 4刘中娟,林嘉友,倪安平,宋耀虹,沈瑛,张时民.系统性红斑狼疮患者血清γ干扰素诱导的蛋白10表达水平与疾病活动的关系[J].中华检验医学杂志,2005,28(1):46-49. 被引量:11
  • 5Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum, 1997, 40: 1725.
  • 6Bombardier C, Gladmann DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 7Neville LF, Mathiak G, Bagasra O. The Immunobiology of interferon-gamma inducible protein 10KD (IP-10): a novel pleiotropic member of the CXC chemokine superfamily. Cytokine Growth Factor Rev, 1997, 8 :207-219.
  • 8Kelly VR, Wuthrich RD. Cytokines in the pathogenesis of systemic lupus erythematosus. Seminars Nephrol, 1999,19 : 57-66.
  • 9夏建国,丁永斌,陈国玉.胃癌候选抑癌基因Syk表达的意义[J].世界华人消化杂志,2004,12(4):767-769. 被引量:10
  • 10Krammer PH. CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol, 1999,71 : 163-210.

二级参考文献13

  • 1Masutani K, Akahoshi M, Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum, 2001, 44:2097-2106.
  • 2Gerard C,Rollins BJ. Chemokines diseases. Nature Immunol, 2001, 2:108-115.
  • 3Hochberg MC. Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 4Bombardier C, Gladmann DD, Urowitz MB,et al. The committee on prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35:630-640.
  • 5Banas B, Luckow B, Moller M, et al. Chemokine and chemokine receptor expression in a novel human messangial cell line. J Am Soc Nephrol, 1999, 10: 2314-2322.
  • 6Neville LF, Mathiak G, Bagasra O. The Immunobiology of interferon-gamma inducible protein 10KD(IP-10): a novel pleiotropic member of the CXC chemokine superfamily. Cytokine Growth Factor Rev, 1997, 8:207-219.
  • 7Eriksson C, Eneslatt K, Ivanoff J, et al. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus. Lupus, 2003,12: 766-774.
  • 8Fujii H, Shimada Y, Hasegawa M, et al. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci, 2004, 35:43-51.
  • 9Yamada M, Yagita H, Inoue H, et al. Selective accumulation of CD4+ T lymphocytes into renal tissue of patients with lupus nephritis. Arthritis Rheum, 2002,46: 735-740.
  • 10Zahir A, Christophe C, Sophie F, et al. Roles of CCR2 and CXCR3 in the T cell mediated response occurring during lupus flares. Arthritis Rheum, 2003,48: 3487-3496.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部